BRAF and colorectal cancer: In retrospect, this unique characteristic of COLO 320DM cells compared to the other CIMP− cell lines might have enabled these cells to tolerate mutant BRAF overexpression, and may explain our difficulties in obtaining BRAFV600E expressing clones in other colorectal cancer cell line such as Caco-2.